Research Working Group      Policy Development Working Group      International Affairs Working Group

Linking Researchers and Industry

  • The Avicenna Alliance is dedicated to ensuring the full innovation cycle of predictive medicine is represented.
  • The Virtual Physiological Human (VPH) Initiative, carries a non-diminishable 50% board representation on the Avicenna Alliance with Industry representatives from Medical Devices, Pharmaceuticals and Software also maintaining a 50% board membership.
  • The VPH Institute is a massive network of Research Organisations and Universities engaged in predictive or in silico medicine.
  • The VPH institute has its origins in a European Commission endorsed research area on computer modeling and simulation and has been active for over 10 years.
  • This partnership of industry and researchers allows the Avicenna Alliance to address challenges to the predictive or in silico market from pre-clinical research all the way to post-market. 

Avicenna Alliance news

Avicenna present at the European Research & Innovation Days

The European Research and Innovation days was a three-day event in Brussels, during which researchers, academics, businesses,...

find out more ›

SAVE THE DATE! Ansys-FDA-Avicenna event in Washington on 11 October 2019

Innovation through healthcare simulationFor those of you who will be in Washington mid-October, ANSYS, in cooperation with the...

find out more ›

Avicenna answers online consultation to shape Horizon Europe

On 23 July the Avicenna Alliance has submitted its opinion to on the strategic priorities of Horizon Europe, the EU’s next framework...

find out more ›

Prestigious FDA award allocated to group that developed the V&V 40 standard

The Avicenna Alliance is proud to announce that some of its working group members have received the FDA Crosscutting Group...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up